A new digital health start up Paige.AI has been launched this week, promising to revolutionise clinical diagnosis and cancer treatment through use of artificial intelligence (AI).
UK diagnostics company Owlstone Medical was among winners of a $1 million award that will help develop new devices for patients with idiopathic pulmonary fibrosis (IPF).